Login to Your Account

Investors Turn More Cautious, Sober Up After Financing 'Party'

By Randall Osborne

Monday, January 7, 2002
After 2000's boom, which brought about a nearly hysterical financial ride for the industry, almost anything would have looked worse. Investors sniffing big profits down the road had jumped aboard the human genome-mapping bandwagon in 2000 with dot-commish glee, which sent valuations rocketing to heights that caused seasoned observers to shake their heads.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription